Clinical Trial Update: Fosamprenavir Expanded Access [Phase 4]

View source ↗

Summary

Phase 4 expanded-access trial update for fosamprenavir (Lexiva) in HIV infection, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lexiva (Fosamprenavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED